The Global Angioedema Treatment Market Report Provides Qualitative And Quantitative Analysis For The Years 2017 To 2025

 

Angioedema Treatment

Angioedema is a medical condition that causes swelling of the lower layer of skin and tissue just beneath the skin, as well as the mucous membrane. Angioedema is classified into four types: allergic angioedema, drug-induced angioedema, idiopathic angioedema, and hereditary angioedema (HAE). Angioedema is caused by a variety of factors, the majority of which are unknown. Angioedema is caused primarily by allergic reactions, adverse effects of medications, genetic defects, and infections. Europe is expected to be the second largest market for global angioedema treatment, with significant growth expected over the forecast period, owing to an increasing number of new manufacturing plants in the region. For example, Shire plc received US Food and Drug Administration approval in January 2018 for the technology transfer of the CINRYZE (C1 esterase inhibitor [human]) drug product manufacturing process to the Vienna, Austria manufacturing site.

 

The global Angioedema Treatment Market Report provides qualitative and quantitative analysis for the years 2017 to 2025. The global angioedema treatment market is expected to grow at a healthy CAGR from 2019 to 2025, according to the report. The study on the angioedema treatment market examines the leading geographies such as North America, Europe, Asia-Pacific, and RoW from 2017 to 2025. The report on the angioedema treatment market is a comprehensive study and presentation of the global angioedema treatment market's drivers, restraints, opportunities, demand factors, market size, forecasts, and trends from 2017 to 2025. Furthermore, the report is a compilation of primary and secondary research findings.

 

HAE patients are given a purified concentrate of C1 esterase inhibitors for both prophylactic and acute attack treatment. Several drugs have been approved for the prevention and treatment of hereditary angioedema. Growth in the global hereditary angioedema treatment market can be attributed to an increase in the prevalence of hereditary angioedema and an increase in global awareness of HAE. During the forecast period, North America dominated the global market due to a comparatively higher reported ratio of hereditary angioedema cases.

Comments

Popular posts from this blog

Vascular Ulcers Treatment focuses on keeping the wound site free of infection during the healing process and relieving edema

Hearing Protection Devices: Often Used To Prevent Noise-Induced Hearing Loss (NIHL)

Electric Wheelchair Market Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028